Bob Fernandez
-
Lawyers, Federal Regulators Critical of Malvern-Based Endo’s Royalties from Drug Opana
Lawyers and federal agencies are arguing that Malvern-based drug maker Endo is still profiting from the disgraced oxymorphone pill also known as Opana ER. Back in…
-
Judge Approves Malvern-Based Endo’s $93,000 Incentives, Employee Bonuses Stalled
Malvern opioid maker Endo International has the greenlight to pay $93,000 in incentives to employees and sales reps, writes Bob Fernandez for The Philadelphia Inquirer.…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
